What mattered more than the headline miss was what the numbers revealed about the underlying business: electrolyzer revenue surged 46% sequentially, but the company's gross losses actually narrowed. That's the real story here. The GenEco electrolyzer segment delivered the quarter's bright spot. Revenue hit $65M, up 46% from Q2 2025, with over 230 MW of electrolyzers now mobilized globally. This is exactly what management has been banking on to drive future profitability. The segment's sequential growth suggests real commercial traction in hydrogen production equipment.
Revenue: $915M, up vs. the $882.3M consensus, but down 33.5% YoY Adjusted EPS: -$0.12 vs. -$0.07 expected Gross margin: 7.2%, down from 11.5% a year ago Net loss: $90M, wider than last year's $78M Cash: $962M, up 16% YoY Q4 outlook: revenue expected down ~35% sequentially on low inventory 1) EPS miss and losses wideningAdjusted EPS of -$0.12 missed by five cents and the net loss expanded to $90M.
